<DOC>
	<DOCNO>NCT01918111</DOCNO>
	<brief_summary>1 . ( RENEWAL-EXERCISE trial ) The investigator hypothesize increase sympathetic nervous system activation associate resistant hypertension major contributor pathogenesis exercise diastolic dysfunction modulation sympathetic nervous system activity radiofrequency ablation renal artery sympathetic nerve fiber deliver via treatment catheter , significant effect diastolic function beyond BP-lowering effect . 2 . ( RENEWAL-REGRESSION trial ) The major cause mortality morbidity hypertension atherosclerotic cardiovascular disease . significant decrease sympathetic nervous system activation renal sympathetic denervation contribute regression beyond 's effect blood pressure reduction . 3 . ( RENEWAL-PREDICT trial ) No data exist regard test method predict successful renal denervation cause effective reduction BP . For , investigator seek perform new test adenosine infusion test procedure skin sympathetic activity measurement immediate post-procedure ( detailed explanation provide section Methods ) evaluate association test reduction BP following procedure .</brief_summary>
	<brief_title>Effects REnal Denervation Resistant Hypertension Exercise Diastolic Function Regression Atherosclerosis Evaluation NEW Methods Predicting A successfuL Renal Sympathetic Denervation ( RENEWAL-EXERCISE , -REGRESS , -PREDICT Trial From RENEWAL RDN Registry )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<criteria>Patients age 2085 year resistant hypertension define systolic BP &gt; 140 mmHg ( &gt; 130 mmHg diabetes ) diastolic BP &gt; 90mmHg ( &gt; 80 mmHg diabetes ) despite adequate administration 3 different class antihypertensive medication include diuretic good adherence adequate treatment regimen . All agent prescribe optimal dose amount . BP base average 3 office BP reading measure accord general guideline . Patients adhere stable drug regimen include 3 antihypertensive medication ( change minimum 2 week prior enrollment ) . Patients provide write , inform consent participate study Hemodynamically anatomically significant renal artery abnormality , main renal artery &lt; 4 mm diameter &lt; 20 mm length , or.prior renal artery intervention Estimated glomerular filtration rate ( eGFR ) &lt; 30mL/min/1.73m2 , use MDRD calculation Hemodynamically significant valvular heart disease History congestive heart failure reduce LV ejection fraction le 35 % CVA prior 3 month STsegment elevation MI within 48 hour Scheduled plan surgery cardiovascular intervention next 6 month . Patients chronic debilitate disease life expectancy le 1 year Patients take hormone replace treatment and/or oral contraceptive ; pregnant , nurse planning pregnant Chronic liver cirrhosis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Renal denervation , Exercise diastolic function , Atherosclerosis , New method</keyword>
</DOC>